Charles Engbers
- Co-authors
- Samuel ZalipskyMartin C. WoodleMary S. NewmanMichael AmanteaGail ColbernPeter K. WorkingNeil I. GoldsteinJennifer Harding
- Topics
- Nanoparticle-Based Drug Delivery (6 papers)Growth Hormone and Insulin-like Growth Factors (3 papers)Cancer Treatment and Pharmacology (3 papers)
- Partner nations
- United StatesUnited KingdomArgentina
In The Last Decade
Charles Engbers
12 papers receiving 875 citations
Peers
Comparison fields: 5 of 87
- Biomaterials 521
- Molecular Biology 471
- Biomedical Engineering 204
- Organic Chemistry 156
- Oncology 124
Countries citing papers authored by Charles Engbers
This map shows the geographic impact of Charles Engbers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Engbers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Engbers more than expected).
Fields of papers citing papers by Charles Engbers
This network shows the impact of papers produced by Charles Engbers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Engbers. The network helps show where Charles Engbers may publish in the future.
Co-authorship network of co-authors of Charles Engbers
This figure shows the co-authorship network connecting the top 25 collaborators of Charles Engbers. A scholar is included among the top collaborators of Charles Engbers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Engbers. Charles Engbers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 70 | |
| 3 | Plasma, tissue and tumor disposition of STEALTH® liposomal CKD-602 (S-CKD602) and non-liposomal CKD-602, a camptothecin analogue, in mice bearing A375 human melanoma xenografts | 3 |
| 4 | Allometric scaling of STEALTH® liposomal anticancer agents | 4 |
| 5 | 239 | |
| 6 | 154 | |
| 7 | 18 | |
| 8 | 47 | |
| 9 | 2 | |
| 10 | 283 | |
| 11 | 35 | |
| 12 | 22 |
About Charles Engbers
Charles Engbers is a scholar working on Biomaterials, Process Chemistry and Technology and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 912 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Biomaterials (521 citations), Surfaces, Coatings and Films (72 citations) and Pharmaceutical Science (52 citations). Charles Engbers has collaborated with scholars based in United States, United Kingdom and Argentina. Frequent co-authors include Samuel Zalipsky, Martin C. Woodle, Mary S. Newman, Michael Amantea, Gail Colbern, Peter K. Working, Neil I. Goldstein, Jennifer Harding, Frank Talamantes and Ross Barnard. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.